Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines

Ruoyu Cheng; Flavia Fontana; Junyuan Xiao; Zehua Liu; Patricia Figueiredo; Mohammad-Ali Shahbazi; Shiqi Wang; Jing Jin; Giulia Torrieri; Jouni Tapio Hirvonen; Hongbo Zhang; Tongtong Chen Chen; Wenguo Cui; Yong Lu; Hélder A. Santos

doi:10.1021/acsami.0c15057

Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines

Ruoyu Cheng, Flavia Fontana, Junyuan Xiao, Zehua Liu, Patricia Figueiredo, Mohammad-Ali Shahbazi, Shiqi Wang, Jing Jin, Giulia Torrieri, Jouni Tapio Hirvonen, Hongbo Zhang, Tongtong Chen Chen, Wenguo Cui, Yong Lu, Hélder A. Santos

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

23 Citeringar (Scopus)

31 Nedladdningar (Pure)

Sammanfattning

Recently, there has been an increasing interest for utilizing the host immune system to fight against cancer. Moreover, cancer vaccines, which can stimulate the host immune system to respond to cancer in the long term, are being investigated as a promising approach to induce tumor-specific immunity. In this work, we prepared an effective cancer vaccine (denoted as "vacosome") by reconstructing the cancer cell membrane, monophosphoryl lipid A as a toll-like receptor 4 agonist, and egg phosphatidylcholine. The vacosome triggered and enhanced bone marrow dendritic cell maturation as well as stimulated the antitumor response against breast cancer 4T1 cells in vitro. Furthermore, an immune memory was established in BALB/c mice after three-time preimmunization with the vacosome. After that, the immunized mice showed inhibited tumor growth and prolonged survival period (longer than 50 days). Overall, our results demonstrate that the vacosome can be a potential candidate for clinical translation as a cancer vaccine.

Originalspråk	Engelska
Sidor (från-till)	44554-44562
Antal sidor	9
Tidskrift	ACS Applied Materials and Interfaces
Volym	12
Nummer	40
DOI	https://doi.org/10.1021/acsami.0c15057
Status	Publicerad - 7 okt. 2020
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Åtkomst av dokument

10.1021/acsami.0c15057Licens: CC BY

Cheng et al., 2020 ACS AMIAccepterat manuskript från författare, 1,2 MBLicens: Publisher rights policy

https://urn.fi/URN:NBN:fi-fe202201147834

Andra filer och länkar

http://dx.doi.org/10.1021/acsami.0c15057

Åbo Akademi Functional Printing Center
Toivakka, M. (PI), Rosenholm, J. (PI), Anttu, N. (PI), Bobacka, J. (PI), Huynh, T. P. (PI), Peltonen, J. (PI), Wang, X. (PI), Wilen, C.-E. (PI), Xu, C. (PI), Zhang, H. (PI) & Österbacka, R. (PI)
Fakulteten för naturvetenskaper och teknik
Utrustning/facilitet: Facilitet

Citera det här

Cheng, R., Fontana, F., Xiao, J., Liu, Z., Figueiredo, P., Shahbazi, M.-A., Wang, S., Jin, J., Torrieri, G., Hirvonen, J. T., Zhang, H., Chen, T. C., Cui, W., Lu, Y., & Santos, H. A. (2020). Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines. ACS Applied Materials and Interfaces, 12(40), 44554-44562. https://doi.org/10.1021/acsami.0c15057

@article{4b00fa458f7f46599b745b3ab1cd0873,

title = "Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines",

abstract = "Recently, there has been an increasing interest for utilizing the host immune system to fight against cancer. Moreover, cancer vaccines, which can stimulate the host immune system to respond to cancer in the long term, are being investigated as a promising approach to induce tumor-specific immunity. In this work, we prepared an effective cancer vaccine (denoted as {"}vacosome{"}) by reconstructing the cancer cell membrane, monophosphoryl lipid A as a toll-like receptor 4 agonist, and egg phosphatidylcholine. The vacosome triggered and enhanced bone marrow dendritic cell maturation as well as stimulated the antitumor response against breast cancer 4T1 cells in vitro. Furthermore, an immune memory was established in BALB/c mice after three-time preimmunization with the vacosome. After that, the immunized mice showed inhibited tumor growth and prolonged survival period (longer than 50 days). Overall, our results demonstrate that the vacosome can be a potential candidate for clinical translation as a cancer vaccine.",

author = "Ruoyu Cheng and Flavia Fontana and Junyuan Xiao and Zehua Liu and Patricia Figueiredo and Mohammad-Ali Shahbazi and Shiqi Wang and Jing Jin and Giulia Torrieri and Hirvonen, {Jouni Tapio} and Hongbo Zhang and Chen, {Tongtong Chen} and Wenguo Cui and Yong Lu and Santos, {H{\'e}lder A.}",

year = "2020",

month = oct,

day = "7",

doi = "10.1021/acsami.0c15057",

language = "English",

volume = "12",

pages = "44554--44562",

journal = "ACS Applied Materials and Interfaces",

issn = "1944-8244",

publisher = "American Chemical Society",

number = "40",

}

Cheng, R, Fontana, F, Xiao, J, Liu, Z, Figueiredo, P, Shahbazi, M-A, Wang, S, Jin, J, Torrieri, G, Hirvonen, JT, Zhang, H, Chen, TC, Cui, W, Lu, Y & Santos, HA 2020, 'Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines', ACS Applied Materials and Interfaces, vol. 12, nr. 40, s. 44554-44562. https://doi.org/10.1021/acsami.0c15057

TY - JOUR

T1 - Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines

AU - Cheng, Ruoyu

AU - Fontana, Flavia

AU - Xiao, Junyuan

AU - Liu, Zehua

AU - Figueiredo, Patricia

AU - Shahbazi, Mohammad-Ali

AU - Wang, Shiqi

AU - Jin, Jing

AU - Torrieri, Giulia

AU - Hirvonen, Jouni Tapio

AU - Zhang, Hongbo

AU - Chen, Tongtong Chen

AU - Cui, Wenguo

AU - Lu, Yong

AU - Santos, Hélder A.

PY - 2020/10/7

Y1 - 2020/10/7

N2 - Recently, there has been an increasing interest for utilizing the host immune system to fight against cancer. Moreover, cancer vaccines, which can stimulate the host immune system to respond to cancer in the long term, are being investigated as a promising approach to induce tumor-specific immunity. In this work, we prepared an effective cancer vaccine (denoted as "vacosome") by reconstructing the cancer cell membrane, monophosphoryl lipid A as a toll-like receptor 4 agonist, and egg phosphatidylcholine. The vacosome triggered and enhanced bone marrow dendritic cell maturation as well as stimulated the antitumor response against breast cancer 4T1 cells in vitro. Furthermore, an immune memory was established in BALB/c mice after three-time preimmunization with the vacosome. After that, the immunized mice showed inhibited tumor growth and prolonged survival period (longer than 50 days). Overall, our results demonstrate that the vacosome can be a potential candidate for clinical translation as a cancer vaccine.

AB - Recently, there has been an increasing interest for utilizing the host immune system to fight against cancer. Moreover, cancer vaccines, which can stimulate the host immune system to respond to cancer in the long term, are being investigated as a promising approach to induce tumor-specific immunity. In this work, we prepared an effective cancer vaccine (denoted as "vacosome") by reconstructing the cancer cell membrane, monophosphoryl lipid A as a toll-like receptor 4 agonist, and egg phosphatidylcholine. The vacosome triggered and enhanced bone marrow dendritic cell maturation as well as stimulated the antitumor response against breast cancer 4T1 cells in vitro. Furthermore, an immune memory was established in BALB/c mice after three-time preimmunization with the vacosome. After that, the immunized mice showed inhibited tumor growth and prolonged survival period (longer than 50 days). Overall, our results demonstrate that the vacosome can be a potential candidate for clinical translation as a cancer vaccine.

UR - http://dx.doi.org/10.1021/acsami.0c15057

U2 - 10.1021/acsami.0c15057

DO - 10.1021/acsami.0c15057

M3 - Article

SN - 1944-8244

VL - 12

SP - 44554

EP - 44562

JO - ACS Applied Materials and Interfaces

JF - ACS Applied Materials and Interfaces

IS - 40

ER -

Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines

Sammanfattning

Åtkomst av dokument

Andra filer och länkar

Fingeravtryck

Utrustning

Åbo Akademi Functional Printing Center

Citera det här